The current valuation score of Inotiv Inc is 9.39, ranking 28 out of 390 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.03, which is 0.00% below the recent high of -0.03 and -26621.50% above the recent low of -8.58.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.